Novavax Inc. Stock Rises 17.4%, Outperforms Peers

Dow Jones
Yesterday

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. jumped 17.4% to $11.19 on what proved to be an all-around dismal trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,499.20 and the NASDAQ Composite Index falling 1.2% to 22,878.38.

This was the stock's fourth consecutive day of gains.

Novavax Inc. hit a new 52-week high, surpassing its previous peak of $10.64, which the company achieved on August 18th.

The stock outperformed some of its peers, as Johnson & Johnson fell 0.7% to $243.47, Pfizer Inc. remained unchanged, and Merck & Co. Inc. fell 2.58% to $119.30.

Trading volume totaled 23.9 million, compared to the 50-day average of 4.6 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 26, 2026 16:33 ET (21:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10